Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for ReposiTrak, Inc. (NYSE: TRAK), a Nevada corporation that operates a cloud-based food traceability, compliance and supply chain data platform. Through these filings, investors can review how the company reports its financial results, corporate actions and governance matters in accordance with SEC requirements.
ReposiTrak’s recent Form 8-K filings include disclosures about quarterly cash dividend declarations on its common stock, authorization of a 10b5-1 share repurchase program under a broader repurchase authorization, earnings releases for fiscal quarters and years, and the results of its annual meeting of stockholders. These current reports also reference attached press releases and earnings call transcripts that provide additional detail on financial performance, capital allocation and operational commentary.
In addition to current reports, ReposiTrak files periodic reports such as Form 10-K annual reports and Form 10-Q quarterly reports, which contain audited or reviewed financial statements, management’s discussion and analysis, risk factor disclosures and information on its business, including its focus on food traceability, regulatory compliance and supply chain solutions delivered through cloud-based applications.
Stock Titan’s filings page is designed to surface these documents as they are made available on EDGAR and to pair them with AI-powered summaries that explain the key points in accessible language. Users can quickly identify items such as dividend announcements, share repurchase authorizations, earnings results and shareholder meeting outcomes, and then drill into the underlying SEC reports for more detail. This same interface can also be used to monitor insider and executive transactions reported on forms such as Form 4, as those become available for ReposiTrak insiders.
ReposiTrak (NASDAQ:TRAK) filed a routine Form 4 on 06/25/2025 disclosing CEO/Chair Randall K. Fields’ automatic Rule 10b5-1 sales of 7,500 common shares for about $150k in aggregate, leaving him with roughly 4.8 million shares across direct and indirect holdings. No change to control or overall ownership percentage.
ReposiTrak CEO Randall K. Fields reported multiple stock sales executed through a Rule 10b5-1 trading plan via his charitable LLC. The transactions occurred over three consecutive days:
- June 16, 2025: Sold 1,500 shares at avg. price of $20.53
- June 17, 2025: Sold 3,500 shares at avg. price of $20.16
- June 18, 2025: Sold 2,500 shares at avg. price of $20.38
Following these transactions, Fields maintains significant holdings: 3,683,955 shares directly owned and substantial indirect ownership through various entities including 615,260 shares via Riverview Financial Corp. The sales were executed to meet charitable commitments. Fields holds multiple roles as Director, 10% Owner, and CEO. Additionally, he has indirect beneficial ownership of Series B Preferred Stock through Riverview Financial Corp (531,432 shares) and his spouse (12,322 shares).